Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$316,439
-$171,966 QoQ
Shares Held
82,192
-33.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 226 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. MDXG ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | TWST |
Twist Bioscience Corp
|
40,732 | $4,190,508 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 |
All Filings in MDXG
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,439 | 82,192 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $488,405 | 123,647 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $469,188 | 69,304 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $462,355 | 66,240 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $384,795 | 62,978 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $498,286 | 65,564 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $483,453 | 50,255 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $657,322 | 111,222 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $957,469 | 138,163 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,219,686 | 288,271 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,593,456 | 181,694 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,637,334 | 224,600 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $887,716 | 134,299 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $584,937 | 171,536 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $491,131 | 176,666 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $467,861 | 163,018 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $366,987 | 105,760 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,002,024 | 212,744 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,302,381 | 215,626 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $479,024 | 79,047 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,170,323 | 93,551 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||